Gene Review:
PRIMA1 - proline rich membrane anchor 1
Homo sapiens
Synonyms:
PRIMA, PRiMA, Proline-rich membrane anchor 1
- Expression proteomics to p53 mutation reactivation with PRIMA-1 in breast cancer cells. Lee, K., Wang, T., Paszczynski, A.J., Daoud, S.S. Biochem. Biophys. Res. Commun. (2006)
- Comparison of TechLab Clostridium difficile Tox-A enzyme immunoassay and Bartels Prima system toxin-A EIA. Forward, K.R., Dalton, M.T., Kerr, E., Paisley, N., Cooper, G. Diagn. Microbiol. Infect. Dis. (1994)
- Performance of stentless versus stented aortic valve bioprostheses in the elderly patient: a prospective randomized trial. Doss, M., Martens, S., Wood, J.P., Aybek, T., Kleine, P., Wimmer Greinecker, G., Moritz, A. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. (2003)
- Effects of PRIMA-1 on wild-type L1210 cells expressing mutant p53 and drug-resistant L1210 cells lacking expression of p53: necrosis vs. apoptosis. Cory, A.H., Chen, J., Cory, J.G. Anticancer Res. (2006)
- PRiMA: the membrane anchor of acetylcholinesterase in the brain. Perrier, A.L., Massoulié, J., Krejci, E. Neuron (2002)
- The synaptic acetylcholinesterase tetramer assembles around a polyproline II helix. Dvir, H., Harel, M., Bon, S., Liu, W.Q., Vidal, M., Garbay, C., Sussman, J.L., Massoulié, J., Silman, I. EMBO J. (2004)
- Assembly of Acetylcholinesterase Tetramers by Peptidic Motifs from the Proline-rich Membrane Anchor, PRiMA: COMPETITION BETWEEN DEGRADATION AND SECRETION PATHWAYS OF HETEROMERIC COMPLEXES. Noureddine, H., Schmitt, C., Liu, W., Garbay, C., Massoulié, J., Bon, S. J. Biol. Chem. (2007)
- Proteomic identification of heat shock protein 90 as a candidate target for p53 mutation reactivation by PRIMA-1 in breast cancer cells. Rehman, A., Chahal, M.S., Tang, X., Bruce, J.E., Pommier, Y., Daoud, S.S. Breast Cancer Res. (2005)
- The origin of the molecular diversity and functional anchoring of cholinesterases. Massoulié, J. Neurosignals (2002)
- Selective induction of apoptosis in mutant p53 premalignant and malignant cancer cells by PRIMA-1 through the c-Jun-NH2-kinase pathway. Li, Y., Mao, Y., Brandt-Rauf, P.W., Williams, A.C., Fine, R.L. Mol. Cancer Ther. (2005)
- Mutant p53-dependent growth suppression distinguishes PRIMA-1 from known anticancer drugs: a statistical analysis of information in the National Cancer Institute database. Bykov, V.J., Issaeva, N., Selivanova, G., Wiman, K.G. Carcinogenesis (2002)
- Stentless aortic bioprosthesis? The way forward: early experience with the Edwards valve. Pillai, R., Spriggings, D., Amarasena, N., O'Regan, D.J., Parry, A.J., Westaby, S. Ann. Thorac. Surg. (1993)
- Aortic valve replacement: is the stentless xenograft an alternative to the homograft? Early results of a randomized study. Gross, C., Harringer, W., Mair, R., Wimmer-Greinecker, G., Klima, U., Sihorsch, K., Hofmann, R., Beran, H., Brücke, P. Ann. Thorac. Surg. (1995)
- Magnetic resonance imaging of stentless xenografts for reconstruction of right ventricular outflow tract. Dohmen, P.M., Hotz, H., Lembcke, A., Kivelitz, D., Hamm, B., Konertz, W. Semin. Thorac. Cardiovasc. Surg. (2001)
- Comparison of four different immunoassays for detection of Toxoplasma-specific immunoglobulin G. Olsen, M.A., Root, P.P. Diagn. Microbiol. Infect. Dis. (1994)
- p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells. Liang, Y., Wu, J., Stancel, G.M., Hyder, S.M. J. Steroid Biochem. Mol. Biol. (2005)
- CP-31398 restores DNA-binding activity to mutant p53 in vitro but does not affect p53 homologs p63 and p73. Demma, M.J., Wong, S., Maxwell, E., Dasmahapatra, B. J. Biol. Chem. (2004)
- Transcriptional control of different acetylcholinesterase subunits in formation and maintenance of vertebrate neuromuscular junctions. Tsim, K.W., Xie, H.Q., Ting, A.K., Siow, N.L., Ling, K.K., Kong, L.W. J. Mol. Neurosci. (2006)
- Genomic characterization and linkage mapping of the apple allergen genes Mal d 2 (thaumatin-like protein) and Mal d 4 (profilin). Gao, Z.S., Weg, W.E., Schaart, J.G., Arkel, G., Breiteneder, H., Hoffmann-Sommergruber, K., Gilissen, L.J. Theor. Appl. Genet. (2005)
- Fifth-year hemodynamic performance of the prima stentless aortic valve. Jin, X.Y., Dhital, K., Bhattacharya, K., Pieris, R., Amarasena, N., Pillai, R. Ann. Thorac. Surg. (1998)
- Genomic cloning and linkage mapping of the Mal d 1 (PR-10) gene family in apple (Malus domestica). Gao, Z.S., van de Weg, W.E., Schaart, J.G., Schouten, H.J., Tran, D.H., Kodde, L.P., van der Meer, I.M., van der Geest, A.H., Kodde, J., Breiteneder, H., Hoffmann-Sommergruber, K., Bosch, D., Gilissen, L.J. Theor. Appl. Genet. (2005)
- Use of stentless xenografts in the aortic position: determinants of early and late outcome. Akar, A.R., Szafranek, A., Alexiou, C., Janas, R., Jasinski, M.J., Swanevelder, J., Sosnowski, A.W. Ann. Thorac. Surg. (2002)
- Beyond stents: third-generation coronary devices. Oesterle, S.N. Ann. Thorac. Surg. (1998)